NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 3 filers reported holding NOVOCURE LTD in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $438,117 | -90.8% | 27,128 | -76.5% | 0.00% | -90.0% |
| Q2 2023 | $4,781,879 | -37.8% | 115,226 | -9.8% | 0.03% | -36.2% |
| Q1 2023 | $7,682,524 | -22.8% | 127,744 | -5.9% | 0.05% | -13.0% |
| Q4 2022 | $9,956,749 | -21.3% | 135,743 | -18.5% | 0.05% | -15.6% |
| Q3 2022 | $12,651,000 | +20.2% | 166,502 | +9.9% | 0.06% | +42.2% |
| Q2 2022 | $10,527,000 | -6.8% | 151,470 | +11.1% | 0.04% | -2.2% |
| Q1 2022 | $11,291,000 | +51.3% | 136,280 | +37.1% | 0.05% | +7.0% |
| Q4 2021 | $7,463,000 | -33.2% | 99,401 | +3.4% | 0.04% | -29.5% |
| Q3 2021 | $11,165,000 | -47.9% | 96,106 | -0.6% | 0.06% | -55.8% |
| Q2 2021 | $21,437,000 | – | 96,642 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $77,833,000 | 15.51% |
| HARTLINE INVESTMENT CORP/ | 302,194 | $67,033,000 | 8.47% |
| Darsana Capital Partners LP | 700,000 | $155,274,000 | 4.42% |
| MORGAN JESS S & CO INC | 23,775 | $5,274,000 | 3.47% |
| Soleus Capital Management, L.P. | 98,975 | $21,955,000 | 3.38% |
| Montanaro Asset Management Ltd | 116,650 | $25,875,000 | 3.26% |
| Taylor Frigon Capital Management LLC | 31,035 | $6,884,000 | 2.15% |
| Rhenman & Partners Asset Management AB | 120,000 | $26,618,000 | 1.81% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $2,218,000 | 1.33% |
| Derbend Asset Management | 5,789 | $1,284,000 | 1.20% |